# Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

> **NCT01955707** · PHASE2 · COMPLETED · sponsor: **Biogen** · enrollment: 161 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** natalizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01955707
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-04
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2016-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955707, "Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01955707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*